NO20075707L - Syntese av bis(tio-hydrazid-amid)salter - Google Patents

Syntese av bis(tio-hydrazid-amid)salter

Info

Publication number
NO20075707L
NO20075707L NO20075707A NO20075707A NO20075707L NO 20075707 L NO20075707 L NO 20075707L NO 20075707 A NO20075707 A NO 20075707A NO 20075707 A NO20075707 A NO 20075707A NO 20075707 L NO20075707 L NO 20075707L
Authority
NO
Norway
Prior art keywords
bis
thiohydrazide amide
solution
thiohydrazide
amide
Prior art date
Application number
NO20075707A
Other languages
English (en)
Norwegian (no)
Inventor
Shoujun Chen
Zhi-Qiang Xia
Original Assignee
Synta Pharmaceuticals Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synta Pharmaceuticals Corp filed Critical Synta Pharmaceuticals Corp
Publication of NO20075707L publication Critical patent/NO20075707L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C327/00Thiocarboxylic acids
    • C07C327/38Amides of thiocarboxylic acids
    • C07C327/56Amides of thiocarboxylic acids having nitrogen atoms of thiocarboxamide groups further bound to another hetero atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/02Systems containing only non-condensed rings with a three-membered ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/04Systems containing only non-condensed rings with a four-membered ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/06Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08Systems containing only non-condensed rings with a five-membered ring the ring being saturated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20075707A 2005-05-16 2007-11-08 Syntese av bis(tio-hydrazid-amid)salter NO20075707L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US68126305P 2005-05-16 2005-05-16
PCT/US2006/018653 WO2006124736A2 (en) 2005-05-16 2006-05-11 Synthesis of bis(thio-hydrazide amide) salts

Publications (1)

Publication Number Publication Date
NO20075707L true NO20075707L (no) 2007-12-11

Family

ID=37057197

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20075707A NO20075707L (no) 2005-05-16 2007-11-08 Syntese av bis(tio-hydrazid-amid)salter

Country Status (16)

Country Link
US (1) US7709683B2 (enExample)
EP (1) EP1888520A2 (enExample)
JP (1) JP2008540658A (enExample)
KR (1) KR20080008399A (enExample)
CN (1) CN101223133B (enExample)
AU (1) AU2006247470B2 (enExample)
BR (1) BRPI0611262A2 (enExample)
CA (1) CA2607890A1 (enExample)
IL (1) IL187056A (enExample)
MX (1) MX2007014314A (enExample)
NO (1) NO20075707L (enExample)
NZ (1) NZ563124A (enExample)
RU (1) RU2407734C2 (enExample)
TW (1) TWI387579B (enExample)
WO (1) WO2006124736A2 (enExample)
ZA (1) ZA200709395B (enExample)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI297335B (en) 2001-07-10 2008-06-01 Synta Pharmaceuticals Corp Taxol enhancer compounds
TWI252847B (en) * 2001-07-10 2006-04-11 Synta Pharmaceuticals Corp Synthesis of taxol enhancers
TWI332943B (en) * 2001-07-10 2010-11-11 Synta Pharmaceuticals Corp Taxol enhancer compounds
TWI330079B (en) 2003-01-15 2010-09-11 Synta Pharmaceuticals Corp Treatment for cancers
WO2006009940A1 (en) 2004-06-23 2006-01-26 Synta Pharmaceuticals Corp. Bis(thio-hydrazide amide) salts for treatment of cancers
US8148426B2 (en) * 2004-11-19 2012-04-03 Synta Pharmaceuticals Corp. Bis(thio-hydrazide amides) for increasing Hsp70 expression
CA2603314A1 (en) * 2005-04-15 2006-10-26 Synta Pharmaceuticals Corp. Methods of increasing natural killer cell activity for therapy
MX2007012688A (es) * 2005-04-15 2008-03-14 Synta Pharmaceuticals Corp Terapia de combinacion para el cancer con compuestos de bis(tiohidrazida) amida.
EP1940375A1 (en) 2005-08-16 2008-07-09 Synta Pharmaceuticals Corporation Bis(thio-hydrazide amide) formulation
US20080176828A1 (en) * 2006-08-21 2008-07-24 Martin Williams Treating melanoma with BIS(THIOHYDRAZIDE AMIDES)
AU2007288340A1 (en) * 2006-08-21 2008-02-28 Synta Pharmaceuticals Corp. Bis (thiohydrazide amides) for treating melanoma
NZ575350A (en) 2006-08-21 2012-02-24 Synta Pharmaceuticals Corp Bis(phenylcarbonothioyl)hydrazide derivatives
EP2059236A2 (en) * 2006-08-21 2009-05-20 Synta Pharmaceuticals Corporation Combination with bis(thiohydrazide amides) for treating cancer
US7939564B2 (en) * 2006-08-31 2011-05-10 Synta Pharmaceuticals Corp. Combination with bis(thiohydrazide amides) for treating cancer
US9498528B2 (en) * 2006-09-13 2016-11-22 Genzyme Corporation Treatment of multiple sclerosis (MS)
TW200829543A (en) * 2006-09-15 2008-07-16 Synta Pharmaceuticals Corp Purification of bis(thiohydrazide amides)
WO2009064374A2 (en) 2007-11-09 2009-05-22 Synta Pharmaceuticals Corp. Oral formulations of bis(thiohydrazide amides)
US8581004B2 (en) 2008-02-21 2013-11-12 Synta Pharmaceuticals Corp. Compounds for treating proliferative disorders
WO2009123704A2 (en) * 2008-03-31 2009-10-08 Synta Pharmaceuticals Corp. Process for preparing bis(thiohydrazide amides)
WO2010048284A1 (en) 2008-10-22 2010-04-29 Synta Pharmaceuticals Corp. Transition metal complexes of bis[thiohydrazide amide] compounds
BRPI0919931A2 (pt) 2008-10-22 2019-09-24 Synta Pharmaceuticals Corp complexos de metal de transição de um composto de bis[tiohidrazida]
US8525776B2 (en) * 2008-10-27 2013-09-03 Lenovo (Singapore) Pte. Ltd Techniques for controlling operation of a device with a virtual touchscreen
WO2010065512A2 (en) 2008-12-01 2010-06-10 Synta Pharmaceuticals Corp. Compounds for treating proliferative disorders
US8822532B2 (en) 2009-12-04 2014-09-02 Synta Pharmaceuticals Corp. Bis[thiohydrazide amide] compounds for treating leukemia
US8815945B2 (en) 2010-04-20 2014-08-26 Masazumi Nagai Use of bis [thiohydrazide amide] compounds such as elesclomol for treating cancers

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2097737A5 (en) 1970-07-14 1972-03-03 Berlin Chemie Veb Virustatic 4-substd 1-acylthiosemicarbazides -from carboxylic acid - hydrazide and isothiocyanates or from carboxylic acid chloride and 4-
DE2037257A1 (en) 1970-07-28 1972-02-03 Farbwerke Hoechst AG, vorm. Meister Lucius & Brüning, 6000 Frankfurt Poly-(5-amino-1,3,4-thiadiazol-2-yl) derivs prepn - intermediates for drug and polymer prodn
US4012360A (en) 1973-12-03 1977-03-15 Ciba-Geigy Corporation Bis-salicyloyl-dicarboxylic acid dihydrazides as stabilizers for polyolefines
JPS5091056A (enExample) 1973-12-17 1975-07-21
US6013836A (en) 1992-02-28 2000-01-11 Rohm And Haas Company Insecticidal N'-substituted-N,N'-disubstitutedhydrazines
FR2697752B1 (fr) 1992-11-10 1995-04-14 Rhone Poulenc Rorer Sa Compositions antitumorales contenant des dérivés du taxane.
ES2139329T3 (es) 1995-09-22 2000-02-01 Bioimage A S Nuevas variantes de la proteina fluorescente verde, gfp.
US6235787B1 (en) 1997-06-30 2001-05-22 Hoffmann-La Roche Inc. Hydrazine derivatives
GB9727524D0 (en) 1997-12-31 1998-02-25 Pharmacia & Upjohn Spa Synergistic antitumor composition containing a biologically active ureido compound
TW479053B (en) 1998-10-19 2002-03-11 Agro Kanesho Co Ltd Hydrazineoxoacetamide derivatives and pesticides
ES2161594B1 (es) 1998-12-17 2003-04-01 Servier Lab Nuevos derivados de la hidrazida, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
US6322303B1 (en) 2000-05-12 2001-11-27 David M. John Dunnage bag and method of making same
EP1164126A1 (de) 2000-06-16 2001-12-19 Basf Aktiengesellschaft Salicylsäurehydrazid-Derivate, Verfahren und Zwischenprodukte zu ihrer Herstellung, sie enthaltende Mittel und ihre Verwendung zur Bekämpfung von Schadpilzen
US6365745B1 (en) 2000-07-14 2002-04-02 Sumika Fine Chemicals Co., Ltd. Method for producing hydrazine derivative
JP2004532187A (ja) 2001-01-25 2004-10-21 ギルフォード ファーマシュウティカルズ インコーポレイテッド 三置換カルボサイクリックサイクロフィリン結合化合物とその用途
US6602907B1 (en) 2001-06-08 2003-08-05 University Of Central Florida Treatment of breast cancer
TWI297335B (en) 2001-07-10 2008-06-01 Synta Pharmaceuticals Corp Taxol enhancer compounds
TWI252847B (en) * 2001-07-10 2006-04-11 Synta Pharmaceuticals Corp Synthesis of taxol enhancers
US6924312B2 (en) 2001-07-10 2005-08-02 Synta Pharmaceuticals Corp. Taxol enhancer compounds
TWI332943B (en) * 2001-07-10 2010-11-11 Synta Pharmaceuticals Corp Taxol enhancer compounds
TW200408407A (en) 2001-11-30 2004-06-01 Dana Farber Cancer Inst Inc Methods and compositions for modulating the immune system and uses thereof
TWI330079B (en) 2003-01-15 2010-09-11 Synta Pharmaceuticals Corp Treatment for cancers
WO2006009940A1 (en) 2004-06-23 2006-01-26 Synta Pharmaceuticals Corp. Bis(thio-hydrazide amide) salts for treatment of cancers
WO2006033913A2 (en) 2004-09-16 2006-03-30 Synta Pharmaceuticals Corp. Bis (thio-hydrazide amides) for treament of hyperplasia
US8148426B2 (en) 2004-11-19 2012-04-03 Synta Pharmaceuticals Corp. Bis(thio-hydrazide amides) for increasing Hsp70 expression
CA2603314A1 (en) 2005-04-15 2006-10-26 Synta Pharmaceuticals Corp. Methods of increasing natural killer cell activity for therapy
MX2007012688A (es) 2005-04-15 2008-03-14 Synta Pharmaceuticals Corp Terapia de combinacion para el cancer con compuestos de bis(tiohidrazida) amida.
WO2006113493A2 (en) 2005-04-15 2006-10-26 Synta Pharmaceuticals Corp. Methods of determining cancer prognosis via natural killer cell activity
EP1940375A1 (en) 2005-08-16 2008-07-09 Synta Pharmaceuticals Corporation Bis(thio-hydrazide amide) formulation

Also Published As

Publication number Publication date
BRPI0611262A2 (pt) 2010-08-24
AU2006247470A1 (en) 2006-11-23
AU2006247470B2 (en) 2010-04-01
RU2007144216A (ru) 2009-06-27
TWI387579B (zh) 2013-03-01
US7709683B2 (en) 2010-05-04
JP2008540658A (ja) 2008-11-20
WO2006124736A2 (en) 2006-11-23
US20060270873A1 (en) 2006-11-30
TW200722411A (en) 2007-06-16
RU2407734C2 (ru) 2010-12-27
MX2007014314A (es) 2008-02-11
KR20080008399A (ko) 2008-01-23
WO2006124736A3 (en) 2007-03-29
NZ563124A (en) 2010-12-24
ZA200709395B (en) 2008-10-29
CA2607890A1 (en) 2006-11-23
IL187056A0 (en) 2008-02-09
CN101223133A (zh) 2008-07-16
EP1888520A2 (en) 2008-02-20
IL187056A (en) 2013-10-31
CN101223133B (zh) 2012-02-29

Similar Documents

Publication Publication Date Title
NO20075707L (no) Syntese av bis(tio-hydrazid-amid)salter
RU2010152758A (ru) Кристаллическая форма и тозилат соединения тетрациклина, кристаллическая форма указанного тозилата и ее полиморфная модификация, способ получения тозилата соединения тетрациклина, полиморфная модификация, полученная указанным способом, и фармацевтические композиции на основе вышеуказанных кристаллической формы и полиморфной модификации
EA200801620A1 (ru) Получение олефинов посредством конверсии кислородсодержащих соединений
GB0418900D0 (en) Novel salt forms
AR078475A1 (es) Procedimiento para preparar una forma cristalina
NZ600035A (en) Method for preparing pyrrolobenzodiazepines, particularly zc-423
EP1854788B8 (en) Method for producing 1-substituted-3-fluoroalkyl pyrazole-4-carboxylate
NO20085417L (no) Krystallinske former av 11beta-(4-acetylfenyl)-20,20,21,21,21-pentafluor-17-hydroksy-19-nor-17alfa-pregna-4,9-dien-3-on
AU2003301508A1 (en) Processes for producing glutamic acid derivative and pyroglutamic acid derivative and novel intermediate for production
Mahato et al. Divergent reaction: metal & oxidant free direct C–H aryloxylation and hydride free formal reductive N-benzylation of N-heterocycles
ATE402173T1 (de) Stereoselektive synthese bestimmter trifluormethylsubstituierter alkohole
EA200400208A1 (ru) Фенилацетамидотиазольные производные, способ их получения и их использования в качестве противоопухолевых средств
AU2010271717A8 (en) Process for producing crystals of polymorphic 2-(3-cyano-4-isobutyloxyphenyl) -4-methyl-5-thiazolecaboxylic acid by poor-solvent addition method
WO2023028168A3 (en) Methods of using antibody-drug-conjugates
RU2012113549A (ru) Кристаллизация 4'-эпидаунорубицина х hci
ATE449098T1 (de) Stereoselektive synthese bestimmter trifluormethylsubstituierter alkohole
Giampietro et al. Asymmetric Tandem Wittig Rearrangement/Mannich Reactions
GEP20125408B (en) New method for obtaining crystal form v of agomelatine
NO20070635L (no) Faste former av magnesiumsalt av S-omeprazol og fremgangsmater for deres fremstilling
DK1877370T3 (da) Fremgangsmåde til fremstilling af hydrazon-derivater
IL193276A0 (en) Process for preparing 1-halo-2,7-naphthyridinyl derivatives
ATE418541T1 (de) Verfahren zur herstellung von carvedilol
TW200740763A (en) A method for preparing 5-hydroxy-1-alkyl pyrazole derivatives
RU2009136314A (ru) НОВЫЙ СПОСОБ ПОЛУЧЕНИЯ 3-МЕТИЛ-4-ФЕНИЛИЗОКСАЗОЛО(3,4-d)ПИРИДАЗИН-7(6Н)-ОНА
DK1745140T3 (da) Biotransformation af colchicinoidforbindelser

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application